obesity-995x60.png
FEATURED ARTICLES
Restoring The American Biotechnology Edge
Michelle Longmire explores why startup delays, enrollment friction, fragmented systems, and rising costs put trials at a competitive disadvantage.
-
![Social Media Communication-GettyImages-1464178609]( "What I Heard When I Crashed Three ING Dive Teams")
What I Heard When I Crashed Three ING Dive TeamsAfter attending three Innovation Network Gathering Dive Teams, Chief Editor Dan Schell shares what he heard about accelerating study startup, rethinking investigator meetings, and leading through AI adoption—along with a reminder that promising ideas still need stakeholder support, measurable evidence, and practical execution.
-
![patient and doctor analyzing medical report-GettyImages-1461330630]( "Can A Universal Health Screening Help Stop Clinical Trial Dropouts?")
Can A Universal Health Screening Help Stop Clinical Trial Dropouts?Could comprehensive health scans give trial participants meaningful value — and help sponsors reduce costly dropouts?
-
![Remote work, hybrid-GettyImages-2065627473]( "Can Your Team Coordinate The CRO Model You've Chosen?")
Can Your Team Coordinate The CRO Model You've Chosen?Choosing the right CRO model matters less than a sponsor’s ability to coordinate it. Here’s how to match outsourcing strategy to internal capacity.
SERVICES AND PRODUCTS
With over 40 years of expertise in cold chain management and a global network of trusted partnerships, we safeguard the integrity of your ultracold supply chain, providing real-time monitoring and assurance for dependable sample storage.
For over 35 years, Thermo Fisher Scientific has supported the clinical trial supply, distribution, and logistics needs of pharmaceutical and biotechnology sponsors globally.
At the center of every clinical trial is a patient waiting for a treatment to arrive safely, securely, and on time. Clinical trial supply services make that possible by ensuring investigational medicinal products (IMPs) are packaged, labeled, stored, and distributed in full regulatory compliance across global study sites
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.